Ophthalmology

1-16 of 78

Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
Ophthalmology
Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
- Jordan Deaner
- Vaidehi S. Dedania, MD
- Rehan M. Hussain, MD
Trends in PDR Treatments
Trends in PDR Treatments
Ophthalmology
Trends in PDR Treatments
- Maria H. Berrocal, MD
- Katharine Talcott, MD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
Eye on Ocular Health
Logistical Considerations with Anti-VEGF Treatment in Wet AMD
GLP-1 Use and AMD Risk
GLP-1 Use and AMD Risk
Ophthalmology
GLP-1 Use and AMD Risk
- Barton Lynn Blackorby, MD
- Katharine Talcott, MD
- Hong-Uyen Hua, MD
MH Risk Factors After RRD Repair
MH Risk Factors After RRD Repair
Ophthalmology
MH Risk Factors After RRD Repair
- Maria H. Berrocal, MD
- Avni P. Finn, MD, MBA
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
Eye on Ocular Health
Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion
- Ashkan Abbey, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Retinal Vein Occlusion: The Case for Prompt Treatment
Eye on Ocular Health
Retinal Vein Occlusion: The Case for Prompt Treatment
- Ashkan Abbey, MD
Identifying Central and Branch Retinal Vein Occlusion
Identifying Central and Branch Retinal Vein Occlusion
Eye on Ocular Health
Identifying Central and Branch Retinal Vein Occlusion
- Jessica Randolph, MD
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular Health
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Outcomes for PDR Patients LTFU for at Least 1 Year
Outcomes for PDR Patients LTFU for at Least 1 Year
Ophthalmology
Outcomes for PDR Patients LTFU for at Least 1 Year
- Kyle Davis Kovacs, MD
- Matt Starr, MD
- Nita Valikodath, MD, MS
Examining Therapeutic Timing in RVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular Health
Examining Therapeutic Timing in RVO-Related Macular Edema
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Ophthalmology
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
- Maria H. Berrocal, MD
- Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
- Ryan Quigley
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- David Chin Yee, MD, FASRS
0.25 credits
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Deepak Sambhara, MD
0.25 credits
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CE
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
0.25 credits
- Esther Lee Kim, MD
0.25 credits

1/5

1-16 of 78

Title

Share on ReachMD